(Q53872718)

21 May 2018

review article

1 reference

title

[Vagal nerve stimulation as a treatment of epilepsy] (English)

1 reference

21 May 2018

author name string

Biraben A

series ordinal

1

1 reference

21 May 2018

Stefani C

series ordinal

2

1 reference

21 May 2018

publication date

1 January 2005

1 reference

21 May 2018

published in

Revue neurologique

1 reference

21 May 2018

volume

161

1 reference

21 May 2018

issue

1

1 reference

21 May 2018

page(s)

128-132

1 reference

21 May 2018

Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus-nerve stimulation for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation, side effects, and long-term safety

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Cerebral activation during vagus nerve stimulation: a functional MR study.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

EEG changes with vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Feasibility and safety of vagal stimulation in monkey model

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Stimulation of the nervous system for the management of seizures: current and future developments

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation has no effect on awake EEG rhythms in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Complications of chronic vagus nerve stimulation for epilepsy in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Vagus nerve stimulation induces a sustained anticonvulsant effect

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Effects of vagal stimulation on experimentally induced seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

Inhibition of experimental seizures in canines by repetitive vagal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2984987-2

7 January 2021

10.1016/S0035-3787(05)84987-2

Identifiers

DOI

1 reference

21 May 2018

PubMed ID

15678011

1 reference

21 May 2018